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Abstract
Introduction: X-linked adrenoleukodystrophy leads to demyelination of the nervous system,
adrenal insufficiency, and accumulation of long-chain fatty acids. Most young patients with X-linked
adrenoleukodystrophy develop seizures and progressive neurologic deficits, and die within the first
two decades of life. Congenital or acquired disorders of the respiratory system have not been
previously described in patients with X-linked adrenoleukodystrophy.
Case presentation: A 3-year-old Arabic boy from Yemen presented with discoloration of the
mucous membranes and nail beds, which were considered cyanoses due to methemoglobinemia.
He also had shortness of breath, fatigue, emesis and dehydration episodes for which he was
admitted to our hospital. Chest radiograph and chest computed tomography scans showed
congenital pulmonary adenomatoid malformation. A few weeks before the removal of the
malformation, he had a significant episode of hypotension and hypoglycemia. This development
required further in-hospital evaluation that led to the diagnosis of adrenal insufficiency and the
initiation of treatment with corticosteroids. One year later, he developed seizures and loss of
consciousness. Magnetic resonance imaging of his head showed diffuse demyelination secondary to
X-linked adrenoleukodystrophy. He was treated with anti-seizure and anti-oxidants, and was
referred for bone marrow transplant evaluation.
Conclusion: The presence of adrenal insufficiency, neurologic deficits and seizures are common
manifestations of X-linked adrenoleukodystrophy. The association of congenital lung disease with
X-linked adrenoleukodystrophy or Addison's disease has not been described previously.
Introduction
X-linked adrenoleukodystrophy (X-ALD) is the most com-
mon inherited peroxisomal disorder with an incidence of
1:20,000 males [1,2]. It is caused by defects of the ABCD1
gene on chromosome Xq28 [1,2]. X-ALD leads to the
impairment of peroxisomal β-oxidation, accumulation of
very long chain fatty acids (VLCFA), progressive demyeli-
nation of the nervous system, and adrenal insufficiency
[1,2]. The phenotypic presentations are highly variable,
which may lead to delayed recognition and misdiagnosis
Published: 14 December 2009
Journal of Medical Case Reports 2009, 3:9329 doi:10.1186/1752-1947-3-9329
Received: 12 November 2009
Accepted: 14 December 2009
This article is available from: http://www.jmedicalcasereports.com/content/3/1/9329
© 2009 Abdulhamid et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Medical Case Reports 2009, 3:9329 http://www.jmedicalcasereports.com/content/3/1/9329
Page 2 of 5
(page number not for citation purposes)
as attention and/or hyperactivity deficit disorder in boys
or multiple sclerosis in adults [1,2].
Hydrocortisone and mineralocorticosteroids are neces-
sary to treat adrenal insufficiency. High doses of hydrocor-
tisone preoperatively and during recovery are needed for
surgery and other stressful illnesses in affected individuals
[3].
Congenital pulmonary adenomatoid malformation
(CPAM) is the most common cystic lung lesion diagnosed
pre- and post-natally [4]. CPAM may lead to respiratory
distress, recurrent lung infections and pulmonary tumors
if not surgically excised [4]. In this report, we describe a
preschool boy who presented with intermittent symp-
toms of respiratory distress, lethargy, dehydration,
hypoglycemia, hypotension, hyperpigmentation and
large CPAM. He was eventually diagnosed with adrenal
insufficiency. He had a surgical removal of the CPAM to
relieve his respiratory distress symptoms, prevent infec-
tions, and thwart cancerous transformation. Subse-
quently, he developed seizures and neurologic symptoms
and was diagnosed with X-ALD after further evaluation.
The association of X-ALD or adrenal insufficiency with
congenital respiratory lesions was not previously reported
in the pediatric age group.
Case presentation
A 3-year-old Arabic boy from Yemen presented with inter-
mittent episodes of shortness of breath, lethargy, fatigabil-
ity, vomiting, and "cyanotic" discoloration of his skin,
lips, mucous membranes and nail beds for the past two
years. He was thought to have methemoglobinemia due
to persistent cyanosis. He was born in Yemen and moved
to the USA for further treatment one year prior to his visit
to our clinic. He was evaluated in several institutions in
Yemen, Europe and the USA for these problems but no
specific diagnosis was ever made. He had one maternal
uncle who died suddenly at 35 years of age and 4 full sib-
lings (all males) who died of unknown causes between 2
and 4 years of age. His deceased siblings had similar
symptoms and discoloration of mucous membranes.
None of them had autopsies. He had 4 other siblings (2
brothers and 2 sisters) who were alive with no medical
problems. He had normal electrolytes, blood urea nitro-
gen (BUN) and creatinine (Cr) levels on several occasions.
He had normal results for cardiac examination, echocardi-
ogram, hematologic evaluation and hemoglobin electro-
phoresis.
He was referred to our center for further evaluation of his
cyanosis. The result of his physical examination was nor-
mal, except for the noted discoloration of his lips and nail
beds. His arterial blood showed mild hypoxemia as fol-
lows: pH 7.32, PaCO2 37.1 mmHg, PaO2 86 mmHg, and
HCO3 18.9. His methemoglobin and carboxyhemo-
globin levels were 1.10% and 0.3%, respectively. He had
a previous chest X-ray during one of his prior admissions
which was interpreted as normal. However, upon further
examination of the film at our clinic, we identified a sub-
tle parenchymal hyperlucency of a large part of his right
mid-lung area (Figure 1). His chest computed tomogra-
phy (CT) scan showed multiple cystic lesions in his right
lung that was compatible with CPAM (Figure 2). CT scan
of the abdomen showed no abnormalities of the adrenal
glands, or other abdominal organs.
Before the surgical removal of his CPAM, he was admitted
with lethargy, vomiting, dehydration, hypotension, and
drowsiness. Laboratory results during this hospitalization
were as follows: glucose, 2.42 mmol/L (44 mg/dl);
sodium, 132 mmol/L; potassuim 3.8 mmol/L; chloride,
101 mmol/L; bicarbonate, 13 mmol/L; BUN, 7.5 mmol/L
(21 mg/dL); Cr, 17.68 umol/L (0.2 mg/dL); calcuim, 2.17
mmol/L (8.7 mg/dL); magnesium, 0.57 mmol/L (1.4 mg/
dL); and phosphorous, 1.2 mmol/L (3.7 mg/dL).
Posteroanterior view of the chest showing hyperlucency in  the right lower lobe area (arrow) Figure 1
Posteroanterior view of the chest showing hyperlu-
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After the initial resuscitation with boluses of 25% dextrose
and normal saline solutions, a repeat glucose test showed
a value of 21.78 mmol/L (396 mg/dL). One hour after
that, his glucose level dropped again to 2.1 mmol/L (39
mg/dl), and a second 25% dextrose solution bolus was
thus given. Our patient had low serum cortisol level, nor-
mal aldosterone, and normal growth hormone concentra-
tions (Table 1). His serum adrenocorticotropic hormone
(ACTH) concentration was elevated at 2,630 pg/ml.
ACTH stimulation test did not result in an increase in his
cortisol levels (Figure 3). He had no detectable anti-adre-
nal antibodies and a non-reactive purified protein deriva-
tive skin test. He was started on hydrocortisone and
fludrocortisone and had a surgical removal of the CPAM
a few weeks later.
Our patient's serum ACTH concentration decreased to 13
pg/ml six months after the treatment. A pathological
examination of the lung cysts showed multiple thin-
walled cysts that ranged from 0.3 cm to 1.5 cm in diameter
and filled with clear fluid. The cysts appeared to occupy
approximately 90% of our patient's parenchyma. Micro-
scopically, the cysts were lined with columnar (respiratory
type) epithelium. This was compatible with the diagnosis
of CPAM.
One year later, he was readmitted with a seizure and loss
of consciousness. A brain magnetic resonance imaging
(MRI) revealed bilaterally diffuse symmetric high T2 and
FLAIR signal abnormality involving the white matter of
several parts of his brain, which was suggestive of a diffuse
and active demyelination process (Figures 4). He had ele-
vated VLCFA levels, which was compatible with the diag-
nosis of X-ALD. His VLCFA levels were as follows: C22:0
of 20.02, C24:0 of 33.61, C26:0 of 1.2, C24 and C22 of
1.679, and C26/C22 of 0.06. Consequently, he was
started on anti-seizure medications N-acetyl-L-cysteine,
and was continued on corticosteroids. He was also
referred for bone marrow transplant evaluation.
Discussion
Our patient and, most likely his deceased uncle and four
brothers had X-ALD. This disorder was probably the cause
of their various constitutional symptoms and the unex-
pected death of his male relatives. X-ALD causes progres-
sive damage of the white matter of the parieto-occipital
Computed tomography scan of the chest showing multiple  cystic lesions of congenital pulmonary adenomatoid malfor- mation in the right lower lobe (arrow) Figure 2
Computed tomography scan of the chest showing 
multiple cystic lesions of congenital pulmonary ade-
nomatoid malformation in the right lower lobe 
(arrow).
Cortisol levels before and after adrenocorticotropic hor- mone stimulation Figure 3
Cortisol levels before and after adrenocorticotropic 
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Table 1: Hormone concentration
Hormone Serum concentration
ACTH 584.386 pmol/L
Fasting cortisol 79.999 nmol/L
Aldosterone 110.988 pmol/L
Growth hormone 4.4 ug/L
Insulin <13.89 pmol/LJournal of Medical Case Reports 2009, 3:9329 http://www.jmedicalcasereports.com/content/3/1/9329
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lobes. It also leads to behavioral problems, motor disabil-
ities, ataxia, hearing deficit, vision loss, seizures, demen-
tia, vegetative state and death within the first 20 years of
life [1]. The diagnosis of X-ALD is confirmed by analyzing
the plasma levels of VLCFAs and identifying aberrant
mutations in the ABCD1 gene [1,2].
Hematopoietic stem cell bone marrow transplant is the
treatment of choice for patients with cerebral X-ALD when
performed at an early stage and in order to ameliorate
neurological sequelea [2,5,6]. Dietary therapy, VLCFA
restriction, the use of levostatin, simvastatin and anti-oxi-
dants such as N-acetyl-L-cysteine may have a beneficial
effect especially when given in early childhood to prevent
further neurologic damage [6-9]. Lorenzo's oil was inef-
fective in cerebral inflammatory disease variants but
asymptomatic patients without cerebral involvement and
female carriers may potentially benefit from the early
intake of oleic and erucic acids [6].
X-ALD is an uncommon cause of adrenal insufficiency [3].
In a series of 103 children with primary adrenal insuffi-
ciency diagnosed over a period of 20 years, only 15% were
found to have X-ALD, various syndromes, or other idio-
pathic causes of adrenal insufficiency [3]. This serious
endocrine gland dysfunction can be life-threatening espe-
cially in the face of stress. In patients with adrenal insuffi-
ciency, treatment with high doses of hydrocortisone is
recommended for stressful events such as a major surgery
or sepsis. Before surgery, a dose of 50 mg/m2 of intrave-
nous hydrocortisone 30 to 60 minutes before the induc-
tion of anesthesia, and a dose of 50 mg/m2 divided every
6 hours over the next 24 hours, can be given. Further high
oral or parenteral stress doses of hydrocortisone can be
continued until the patient recovers [3].
Skin and mucous membrane hyperpigmentation may
occur due to the elevation of proopiomelanocortin and
melanocyte-stimulating hormones [3]. The usual pattern
of pigmentation in adrenal insufficiency is more evident
in sun-exposed regions, in areas exposed to chronic fric-
tion or pressure, in the palmar creases, and in normally
pigmented areas [10,11]. Oral mucosal hyperpigmenta-
tion is considered pathognomonic of adrenal insuffi-
ciency. The lesions tend to be blue, black or brown
macules in a streaky or spotted fashion [10,11]. The uni-
form and unusual discoloration of the lips and mucosal
surfaces seen in our patient was not typical of adrenal defi-
ciency, which might have contributed to the delayed diag-
nosis of his underlying neurologic and endocrine
disorders.
CPAM is a space-occupying lesion composed of various
types of hamartomatous anomalies believed to occur as a
result of abnormal branching of immature airways during
early lung development [4,12,13]. It is the most common
congenital cystic lung disease and is believed to result
from insults to the developing lung at 5 to 22 weeks of
gestation. Three histopathological types were originally
described by Stocker while two more subtypes were added
by other authors [4,13].
CPAM, especially type II, is associated with other congen-
ital anomalies such as renal agenesis, cardiac anomalies,
pulmonary hypoplasia, pectus excavatum, and anasarca
[13]. A majority of cases (83%) present in early post-natal
period with respiratory distress, and generalized edema
[13]. Some surgeons recommend conservative follow-up
for asymptomatic cases but most authors recommend the
surgical removal of the CPAM to treat respiratory distress
and to prevent infections and cancerous transformations
since up to 8.6% of primary lung tumors in the first two
decades of life were associated with CPAM and lung cysts
[4]. CPAM can be safely removed with excellent prognosis
and virtually no morbidity or mortality occurs especially
in centers with adequate experience in lung resection [4].
The association of CPAM and Addison's disease or X-ALD
seen in our patient has not been described in the past. We
do not know if the development of CPAM was related to
prenatal adrenal insufficiency and low corticosteroid con-
Magnetic resonance imaging of the brain showing bilateral  symmetric demyelination of various parts of the brain Figure 4
Magnetic resonance imaging of the brain showing 
bilateral symmetric demyelination of various parts of 
the brainPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Medical Case Reports 2009, 3:9329 http://www.jmedicalcasereports.com/content/3/1/9329
Page 5 of 5
(page number not for citation purposes)
centrations in this child. However, normal adrenocortical
function is most likely important for the growth and mat-
uration of lung tissues during the early intrauterine life
[14]. Few articles reported interesting relationships
between adrenocortical function and respiratory disorders
in the pediatric age group. The prenatal maternal use of
steroids may lead to accelerated lung maturation and
reduction in the size of hamartomatous lesions [4]. At
least two authors described either the resolution of
hydrops fetalis secondary to CPAM or the reduction in the
size of CPAMs with prenatal maternal betamethasone or
dexamethasone therapy [4].
Conclusion
We described a 3-year-old boy with X-ALD, adrenal insuf-
ficiency and CPAM. The early and accurate diagnosis and
treatment of patients with X-ALD and its complications
can delay progressive degenerative changes and attenuate
further neurologic and metabolic dysfunction. The surgi-
cal removal of CPAM is recommended by most authors to
treat respiratory distress and to prevent infections and
malignant transformation. This is an original case report
that may be of particular interest to pediatricians in gen-
eral and of special importance to certain subspecialists
such as pediatric endocrinologists, pulmonologists and
neurologists.
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